Treating acute pancreatitis: what's new?

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Pharmacology

Background:

• Acute pancreatitis management primarily involves supportive care, including fluid therapy, nutrition, and antibiotics.
• Previous pharmacologic treatments have shown limited efficacy due to target specificity and trial design limitations.

Purpose of the Study:

• To critically review current supportive care strategies for acute pancreatitis.
• To discuss potential future pharmacologic agents and optimized trial designs for acute pancreatitis treatment.
• To address the increasing incidence of acute pancreatitis and its impact on healthcare costs.

Main Methods:

• Critical review of existing literature on supportive care for acute pancreatitis.
• Analysis of previously studied pharmacologic agents and their limitations.
• Discussion of novel therapeutic targets, such as intracellular calcium signaling.
• Considerations for future clinical trial design in acute pancreatitis research.

Main Results:

• Supportive care remains the cornerstone of acute pancreatitis treatment.
• Past pharmacologic interventions have largely failed to demonstrate significant benefits.
• Intracellular calcium signaling presents a promising target for future drug development.

Conclusions:

• Further research into novel pharmacologic agents and improved clinical trial methodologies is crucial for advancing acute pancreatitis treatment.
• Preventing hospitalizations, readmissions, and unnecessary imaging is essential for reducing healthcare expenditure associated with acute pancreatitis.
• Primary and secondary prevention strategies, including post-ERCP pancreatitis prophylaxis and cholecystectomy, remain vital.